China National Medicines Stock Shares Outstanding

600511 Stock   31.92  0.11  0.35%   
China National Medicines fundamentals help investors to digest information that contributes to China National's financial success or failures. It also enables traders to predict the movement of China Stock. The fundamental analysis module provides a way to measure China National's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to China National stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

China National Medicines Company Shares Outstanding Analysis

China National's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.

Shares Outstanding

 = 

Public Shares

-

Repurchased

More About Shares Outstanding | All Equity Analysis

Current China National Shares Outstanding

    
  754.5 M  
Most of China National's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, China National Medicines is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Competition

Based on the latest financial disclosure, China National Medicines has 754.5 M of shares currently outstending. This is much higher than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The shares outstanding for all China stocks is notably lower than that of the firm.

China Shares Outstanding Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses China National's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of China National could also be used in its relative valuation, which is a method of valuing China National by comparing valuation metrics of similar companies.
China National is currently under evaluation in shares outstanding category among its peers.

China Fundamentals

About China National Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze China National Medicines's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of China National using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of China National Medicines based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

Other Information on Investing in China Stock

China National financial ratios help investors to determine whether China Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in China with respect to the benefits of owning China National security.